MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson’s Candidate, Stock Soars

MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson’s and CNS treatments.
March 13, 2025